LabCompass

Rachel A. Katzenellenbogen

Medicine · Indiana University

OpenAlex ORCID
Established · publishing since 1994Rising activity
Cervical Cancer and HPV ResearchTelomeres, Telomerase, and SenescenceNF-κB Signaling PathwaysT-cell and Retrovirus StudiesVirus-based gene therapy research

Publications

76

Citations

1,872

Est. group size

—

Recurring co-author estimate

Active years

33

Publishing since 1994

Research summary
AI-generated

Rachel A. Katzenellenbogen studies human papillomavirus (HPV), the virus responsible for cervical and other cancers, with a focus on how viral proteins interact with cellular machinery like telomerase (an enzyme linked to cell aging and cancer growth) and cell-signaling pathways. Her work spans laboratory studies of how HPV drives cancer as well as public-health topics such as HPV vaccination and cancer prevention in children and immunocompromised patients. She has also written extensively about scientific career development and mentorship.

HPV and cervical cancer biologyHPV vaccination and cancer preventionTelomerase and cell-signaling pathwaysCancer prevention in children and immunocompromised patientsScientific career development and mentorship

Publication activity has been irregular over the past decade, with notable peaks in 2019 and 2024 and a recent 5-year average of about five publications per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

No award with a current end date on record.

3 earlier awards
  • NIH U54CA254518Sep 2020 – Aug 2026 · $144k awarded

    Project 3-- Determining biological and viral factors associated with clinical progression of cervical dysplasia in HIV-infected women

  • NIH R01CA172742Jun 2014 – May 2026 · $68k awarded

    High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers

  • NIH R21AI135155May 2018 – May 2021 · $197k awarded

    Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 4,953 established Medicine PIs within our index
Citations: 1,872cohort median 2,544
h-index: 19cohort median 24
Publications / year (recent): 5.0cohort median 4.8

Typically publishes in teams of ~2 · 81% small-team papers (≤3 authors) · across 12 venues

Publication cadence
Publications per year over the last 10 years — averaging 5.0/year recently
2017: 2 publications17182019: 17 publications17192020: 4 publications202021: 5 publications212022: 3 publications222023: 3 publications232024: 13 publications242025: 5 publications252026: 1 publication26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 0 collaborators at the same institution2024: 2 collaborators at the same institution2025: 0 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Viruses×2
  • Cancers×2
  • Journal of Medical Virology×2
  • JAMA Pediatrics×2
  • Journal of Virology×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 27, 2026.

Claim or correct this profile